Phys Vivas · rheumatological
Drug Induced Rheumatological Disease AND Biologics Safety — Viva Defence
DCE viva defence for Drug Induced Rheumatological Disease AND Biologics Safety.
On this page & tools
Target exams
Drug Induced Rheumatological Disease AND Biologics Safety Viva
Long Case Viva Defence
Opening statement
"This patient presents with a problem best framed as Drug Induced Rheumatological Disease AND Biologics Safety. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]
Examiner questions
Q1: "What makes this urgent?" [1]
"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]
Q2: "What is your first investigation package?" [2]
"I order tests that change management now, not a scattergun panel." [1] [2]
Q3: "Walk me through treatment." [1]
"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]
Q4: "What is the classic trap?" [2]
"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]
Short case
Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]
References
- [1]Pandey SN, Babu MA, Goyal K, Menon SV, et al. Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammation Inflammopharmacology, 2025.PMID 40928616
- [2]Dans-Caballero S, Cecchi I, Radin M, Sciascia S JAK inhibitors for the management of rheumatic diseases when antiphospholipid syndrome co-exists: case-based safety considerations Lupus, 2025.PMID 40393677
- [3]Sciascia S, Foddai SG, Arbrile M, Radin M, et al. Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review Immunol Res, 2024.PMID 38459403
- [4]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [5]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
- [6]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
- [7]D'Gama JD, Bermas BL Safety of biologic agents for the management of rheumatic diseases during pregnancy Curr Opin Rheumatol, 2024.PMID 38456470
- [8]Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, Giménez-Richarte Á, et al. Exposure to biologic therapy before and during pregnancy in patients with psoriasis: Systematic review and meta-analysis J Eur Acad Dermatol Venereol, 2023.PMID 37262303